31 August 2026
In plain English
Quiet day on the science, loud day on the plumbing.
The one thing worth the operator's morning is not a forecast. Eight days ago every automated job in this system stopped running, and it is still stopped. That includes the job that carries work orders out to the product sites, so the orders written on the 28th, 29th, 30th and today are sitting in a file instead of arriving anywhere.
On the forecasts themselves: I caught myself making a mistake and undid it. Over the past week I have been steadily lowering the odds that Hims & Hers (a large telehealth company) launches its own line of experimental drugs called peptides — short protein fragments used for recovery and longevity — because the company kept appearing in bad headlines. Checking the date showed the underlying event, a government lawsuit about the company's billing and privacy practices, was filed on 29 July. The recent headlines were share-price reaction to a month-old story, not news. I had been counting the same fact over and over. The odds go back up, and I have flagged the forecast so a human decides rather than me.
One more for the operator: the prediction that a major US news outlet would publish a big investigation into peptide injuries appears to have already come true, twice, back in July. It has been stuck at its maximum value for seven days running. It needs a human to close it.
Signal detail
Two offsetting non-primary items. Truveta reports record Medicare GLP-1 adoption (2026-08-29); MM&M reports that some sick patients do not qualify (same day). The adoption datum is the more on-point for an enrollment-threshold question, so it moves the number — but Truveta measures dispensing across its own network and this forecast resolves on CMS Part D enrollment. Deliberately a smaller move than yesterday's −0.05 on similar material.
NBC News, "Who's tracking the risks from peptides? In many cases, no one" (2026-08-27) is the third major-outlet peptide-risk feature in five weeks. NBC is not one of the five outlets the forecast names, so it adds weight without adding a resolver. See §3.
Nothing today bears on our own affiliate mix. Augur. Federal investigators traced IV reactions at multiple wellness clinics to a single shared ingredient lot (2026-08-29). The interesting part is the topology, not the incident: this is a supply-chain single-point-of-failure story rather than a bad-actor-pharmacy story. If peptide APIs share that shape — and a handful of suppliers do serve many compounders — then contamination risk across vendors is correlated, not independent, which changes the shape of the safety risk and not merely its level. I am deliberately not writing this into a work order: the reported event is IV wellness clinics, not peptides, and asserting the link would be the INFERENCE defect class the digest already charges me with seven times.
Resolutions & upcoming
Nothing overdue. All four pending forecasts resolve 2026-12-31 or later; none inside 14 days.
ESCALATION — `peptide-safety-incident` needs an operator call. It has sat at the 0.95 ceiling for seven consecutive runs and cannot move. Two candidate resolvers inside the forecast's named outlet list have been on record since early August: WaPo 2026-07-24 (state oversight of the peptide boom) and CNN 2026-07-31 (inside the gray-market peptide industry). Only the operator can judge whether either clears the "major feature" bar. A forecast pinned at ceiling with its resolving event apparently already in hand is dead weight in the log, and it has been dead weight for a week.
How Barque got smarter today
- The order-defect digest returned 124 defects across 35 orders in 14 days — 116 corrected-and-shipped on 33 orders, 8 that stopped 2 orders. Top three classes, in rank order: UNCLASSIFIED 31, OMISSION 18, PREMISE-FALSE 11. And I cannot see all of it: 25 more were counted by the resolver and cut off by the notes budget, plus 31 unclassified, so roughly 45% of the channel is invisible to me. I am reporting the visible part as the visible part. Mechanical changes against the top three, not intentions: (1) OMISSION — the HRTPICKS order below states its scope as the title and nothing below it and forbids naming agents the abstract was not read for; (2) PREMISE-FALSE — I ran the `NOT_YET_RECRUITING` check below before writing, not after; (3) UNCLASSIFIED is not actionable as a class, and the amendment that would make it so is a brief change I cannot make myself: proposed verbatim for the operator to commit — in STEP V, add "a resolver recording a defect writes `CLASS=` from the enumerated list; `UNCLASSIFIED` is not a permitted value and an unenumerated class is itself a channel defect."
- A PREMISE-INVERTED defect from 2026-08-29 stopped a bad order today, which is the calibration loop actually closing. The liraglutide order was charged with reading a `status` field as a substantive change when `status` and `availability` are two different fields. Today the digest surfaced NCT07760948 (HMB + vitamin D for muscle loss on semaglutide) with a 2026-08-28 record update, and the existing glp1picks page says the trial "has not enrolled anyone." I checked the substantive field before writing the order: `status: NOT_YET_RECRUITING`. The page is still right. A record update is not an enrolment change, and the order I was about to write would have been wrong in exactly yesterday's way. No order filed.
- I caught the Hims double-count in myself, and the council structure is what caught it. The Historian's question — is this a new event or the same event again — is cheap and I had not been asking it. Candidate heuristic for the Evolution Log: before any probability move driven by a news cluster, date the underlying event, not the coverage. Coverage volume tracks salience; only the event date tracks information.
- A silently undeliverable work order, and a checker that reports it as an expected wait. `thecompound-update-claude-md-gsc-now-connected` (2026-08-30) uses product token `THECOMPOUND`. The dispatcher maps ten tokens and `THECOMPOUND` is not one — but it is a near-miss for `COMPOUND`, which maps to a repo that has existed all along. `check-workflow-product-maps.py` exits 0 and prints "orders for it defer until the product ships," the right sentence for SKINANALYSIS and the wrong one here. Ordered below.
- Reroutes: no new reroutes this cycle. Two `REROUTE:` rows exist (both 2026-08-03, both to BESTPEPTIDEFORTHAT) and both were re-filed by prior runs. Channel read, ordinary answer.
- Which rung of STEP V I dropped, and why it was not a choice. Tier 0 carried this entire run. Tier 1 is dead — measured today, run 33356264594, six seconds. Tier 2 I spent once, on the Hims date. Every specific in today's orders is therefore either verified from the on-disk PRIMARY digest, verified from a file in this repo, or carries an explicit `UNVERIFIED:` token. The mark was never dropped.